Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 10/20 | 0.69 |
| ▸ | GNAI1 | P63096 | 10/20 | 0.69 |
| ▸ | GNAO1 | P09471 | 9/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9120685 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL6536788 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL9658815 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL18651303 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL6488462 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL3601270 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL23533349 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL8973027 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL8973060 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL9415674 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0268222-B1 | Penetration enhancers for transdermal delivery of systemic agents | RES TRIANGLE PHARM LTD (US) | 1996-03-27 | — | — | EP | claimed |
| US-4917896-A | PIPERAZINE, MORPHOLINE OR THIOMORPHOLINE DERIVATIVE | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1990-04-17 | — | — | US | claimed |
| EP-0268222-A2 | Penetration enhancers for transdermal delivery of systemic agents | RESEARCH TRIANGLE PHARMACEUTICALS LTD. (US) | 1988-05-25 | — | — | EP | claimed |
| WO-2025226833-A1 | LIVER RECEPTOR HOMOLOG-1 (LRH-1) AGONIST ISOSTERES AND USES | EMORY UNIVERSITY (US) | 2025-10-30 | — | — | WO | disclosed |
| EP-0268222-B1 | Penetration enhancers for transdermal delivery of systemic agents | RES TRIANGLE PHARM LTD (US) | 1996-03-27 | — | — | EP | disclosed |
| US-4917896-A | PIPERAZINE, MORPHOLINE OR THIOMORPHOLINE DERIVATIVE | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1990-04-17 | — | — | US | disclosed |
| EP-0268222-A2 | Penetration enhancers for transdermal delivery of systemic agents | RESEARCH TRIANGLE PHARMACEUTICALS LTD. (US) | 1988-05-25 | — | — | EP | disclosed |